Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New hope for hard-to-treat head and neck cancer: drug combo shows promise in early trial

NCT ID NCT07589049

First seen May 18, 2026 · Last updated May 24, 2026 · Updated 1 time

Summary

This study tests a new two-drug combination for people with recurrent head and neck cancer that has stopped responding to standard immunotherapy and chemotherapy. The drugs are given before surgery to shrink the tumor, followed by standard treatments and maintenance therapy. The goal is to see if this approach can improve outcomes for 42 participants across 11 centers in China.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Affiliated Hospital of Guangdong Medical University

    Zhanjiang, Guangdong, China

  • Cancer Hospital of Guangzhou Medical University

    Guangzhou, Guangdong, China

  • Cancer Hospital of Shantou University Medical College

    Shantou, Guangdong, China

  • Ganzhou Cancer Hospital

    Ganzhou, Jiangxi, China

  • Guangdong Provincial People's Hospital

    Guangzhou, Guangdong, China

  • Guangzhou First People's Hospital

    Guangzhou, Guangdong, China

  • Qingyuan People's Hospital

    Qingyuan, Guangdong, China

  • Shenzhen Second People's Hospital

    Shenzhen, Guangdong, China

  • Sun Yat-sen University Cancer Center

    Guangzhou, Guangdong, China

  • The First People's Hospital of Foshan

    Foshan, Guangdong, China

  • The Third Affiliated Hospital of Sun Yat-sen University

    Guangzhou, Guangdong, China

  • Zhujiang Hospital of Southern Medical University

    Guangzhou, Guangdong, China

Conditions

Explore the condition pages connected to this study.